MetLife, Inc. (MET) Financials
MET Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 748.1 billion | 720.3 billion |
| March 31, 2026 | 743.2 billion | 715.4 billion |
| Dec. 31, 2025 | 745.2 billion | 716.2 billion |
| Sept. 30, 2025 | 719.7 billion | 690.5 billion |
MET Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 2.2 billion | ? |
| March 31, 2026 | 2.7 billion | ? |
| Dec. 31, 2025 | 8.1 billion | ? |
| Sept. 30, 2025 | 3.6 billion | ? |
MET Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | -1.2 billion |
| March 31, 2026 | 1.2 billion |
| Dec. 31, 2025 | 809.0 million |
| Sept. 30, 2025 | 896.0 million |
MET Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 338.8 billion | 19.9 billion | - |
| March 31, 2026 | 338.8 billion | 19.9 billion | - |
| Dec. 31, 2025 | 125.3 billion | 18.6 billion | 6.0 million |
| Sept. 30, 2025 | 122.1 billion | 19.5 billion | - |
MET Shares Outstanding
MET Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | - | 1.7 billion | - |
| March 31, 2026 | - | - | 1.7 billion | - |
| Dec. 31, 2025 | - | - | 3.7 billion | - |
| Sept. 30, 2025 | - | - | 1.5 billion | - |
MET Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 18.9 billion | 16.1 billion |
| March 31, 2026 | 19.1 billion | 12.0 billion |
| Dec. 31, 2025 | 23.8 billion | 16.5 billion |
| Sept. 30, 2025 | 16.9 billion | 13.9 billion |
MET Revenue by Segment
MET
Price: $97.62
Dividend Yield: 2.34%
Forward Dividend Yield: 2.43%
Payout Ratio: 59.24%
Dividend Per Share: 2.37 USD
Earnings Per Share: 5.21 USD
P/E Ratio: 18.58
Exchange: NYQ
Sector: Financial Services
Industry: Insurance - Life
Country: United States
Volume: 2.2 million
Ebitda: 817.5 millionMarket Capitalization: 63.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR3: 4.32%
DGR5: 4.33%
DGR10: 5.63%
DGR20: 7.92%